Monash University

This early-phase study tests a new drug called STX-1150 that aims to lower 'bad' LDL cholesterol by temporarily silencing a gene in the liver. About 64 adults with high cholesterol will receive one or more doses and be followed for up to a year. The main goal is to check safety a…

This study follows 800 pregnant women with a BMI of 30 or higher to see if experiencing weight stigma leads to worse pregnancy outcomes, like gestational diabetes. Researchers will track factors like weight cycling, trauma, and eating disorders. No treatment is given—this is an o…